Parrish Capital LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2131053 KENNESAW, GA

Position in GILD

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$3,170,110

+$237,238 QoQ

Shares Held

22,746

-4.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

2.85%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Parrish Capital LLC holds $8,791,854 across 4 Drug Manufacturers - General names. GILD ranks #1 (36.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	22,746	$3,170,110
2	AZN	Astrazeneca PLC	11,555	$2,278,877
3	ABBV	AbbVie Inc.	7,862	$1,709,906
4	GSK	GSK plc	29,588	$1,632,961

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,170,110	22,746	-4.8%	Shares	Sole	2026-04-28
2025-12-31	$2,932,872	23,895	—	Shares	Sole	2026-04-28
No filing history on record for this holder in this stock.